TGFB1 and cancer: Drawing from these observations, the present report proposes that the difference in circulating TGF-β, could be accountable for the increased risk of various cancer types among individuals with neutrophilic asthma in comparison to those with AR, while the interference of the TGF-β/Smad signaling pathway leads to an opposite outcome.